Drug Profile
HuGOH 729S
Alternative Names: HuGOH729S; HuGOH729S MultYbody™Latest Information Update: 28 Jun 2021
Price :
$50
*
At a glance
- Originator JN Biosciences
- Class Antibodies; Antineoplastics; Immunotherapies
- Mechanism of Action TRAIL receptor 2 agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 28 Jun 2021 No recent reports of development identified for research development in Cancer in USA (Parenteral)
- 24 May 2017 Early research in Cancer in USA (Parenteral) before May 2017 (JN Biosciences pipeline, May 2017)